HER2 Expression / Amplification in Patients With Biliary Tract Cancer Clinical Trials in Shanghai, Shanghai Municipality

Phase II Clinical Study of SHR-A1811 in Patients With HER2 Expression / Amplification of Locally Advanced Unresectable or Recurrent Metastatic Biliary Tract Cancer